Related Experiment Videos
[Treatment of acute lymphoblastic leukaemia in children over twenty years (author's transl)]
Insights
This review shows significant progress in treating childhood acute lymphoblastic leukemia (ALL). Advances in therapy improved outcomes for all patients, especially those with poor initial prognosis.
Area of Science:
- Pediatric Oncology
- Hematology
- Clinical Research
Background:
- Acute lymphoblastic leukemia (ALL) is a significant childhood cancer.
- Treatment advancements over two decades have impacted patient outcomes.
- A large cohort provides a robust dataset for analysis.
Purpose of the Study:
- To review treatment progress for childhood acute lymphoblastic leukemia (ALL).
- To analyze the impact of therapeutic additions on patient outcomes.
- To evaluate the role of individual treatment components.
Main Methods:
- Retrospective analysis of 1580 children treated for ALL between 1956-1976.
- Classification of patients into three prognostic groups.
- Categorization of treatments into five therapeutic types.
Main Results:
- Conspicuous benefits observed across all prognostic classes and therapeutic categories.
- Striking improvements noted particularly in children with poor initial prognosis.
- Analysis highlights the additive benefits of successive therapeutic advancements.
Conclusions:
- Therapeutic progress has demonstrably improved outcomes in childhood ALL.
- Specific treatment components contribute significantly to overall efficacy.
- Further research into optimizing therapeutic strategies is warranted.
Abstract:
This is a review of the progress achieved in the treatment of acute lymphoblastic leukaemia, based on a series of 1580 children treated in Prof. Jean Bernard's unit, Paris, from 1956 to 1976. The children are retrospectively divided into three prognostic classes and five therapeutic categories. The benefits obtained from successive additions to the therapeutic armentarium during that period are conspicuous in all classes and categories and particularly striking in children with poor initial prognosis. The role of each component of the therapeutic measures applied is discussed.